Keyword: Ron Wyden

Sen. Chuck Grassley wants to know what HHS and CMS are doing to prevent genetic testing fraud after a massive group of arrests.

A Senate committee advanced a major legislative package to tackle high drug prices.

The Senate Finance Committee has finally unveiled its long-awaited legislation on drug prices. 

Two senators are asking the OIG to investigate pharmacy benefit managers' business practices, in particular controversial spread pricing models.

Pharmacy benefit managers warn that eliminating drug rebates puts little pressure on pharmaceutical companies to drive down costs.

Pharma CEOs went before the Senate last month, and now it’s PBMs’ turn to be on the hot seat. 

Republicans and Democrats found an issue they could agree on this week: They are particularly unhappy with drugmakers.

Health IT and behavioral health groups are backing the eTREAT Act to remove telehealth restrictions for substance abuse treatment.

Republicans represent much of rural America, but are many of their policies hurting providers in those areas?

Democratic leaders in both chambers are asking GAO to investigate how many federal and state dollars are being spent on Medicaid work requirements.